• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

饮食和营养管理在非酒精性脂肪性肝病中的作用。

Role of diet and nutritional management in non-alcoholic fatty liver disease.

机构信息

Department of Gastroenterology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Children's Digestion and Nutrition, Shanghai, China.

出版信息

J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:81-7. doi: 10.1111/jgh.12244.

DOI:10.1111/jgh.12244
PMID:24251710
Abstract

Non-alcoholic fatty liver disease (NAFLD) encompasses a spectrum ranging from simple steatosis to non-alcoholic steatohepatitis, which causes an increased risk of cirrhosis, type 2 diabetes, and cardiovascular complications. With the worldwide growing incidence of obesity, sedentary lifestyle, and unhealthy dietary pattern, NAFLD has currently been recognized as a major health burden. Dietary patterns and nutrients are the important contributors to the development, progression, and treatment of NAFLD and associated metabolic comorbidities. Generally, hypercaloric diet, especially rich in trans/saturated fat and cholesterol, and fructose-sweetened beverages seem to increase visceral adiposity and stimulate hepatic lipid accumulation and progression into non-alcoholic steatohepatitis, whereas reducing caloric intake, increasing soy protein and whey consumption, and supplement of monounsaturated fatty acids, omega-3 fatty acids, and probiotics have preventive and therapeutic effects. In addition, choline, fiber, coffee, green tea, and light alcohol drinking might be protective factors for NAFLD. Based on available data, at least 3-5% of weight loss, achieved by hypocaloric diet alone or in conjunction with exercise and behavioral modification, generally reduces hepatic steatosis, and up to 10% weight loss may be needed to improve hepatic necroinflammation. A sustained adherence to diet rather than the actual diet type is a major predictor of successful weight loss. Moreover, a healthy diet has benefits beyond weight reduction on NAFLD patients whether obese or of normal weight. Therefore, nutrition serves as a major route of prevention and treatment of NAFLD, and patients with NAFLD should have an individualized diet recommendation.

摘要

非酒精性脂肪性肝病(NAFLD)涵盖了从单纯性脂肪变性到非酒精性脂肪性肝炎的一系列病变,后者会增加肝硬化、2 型糖尿病和心血管并发症的风险。随着全球肥胖、久坐不动的生活方式和不健康饮食模式的发生率不断上升,NAFLD 目前已被认为是一个主要的健康负担。饮食模式和营养物质是 NAFLD 及其相关代谢性合并症发展、进展和治疗的重要因素。一般来说,高热量饮食,尤其是富含反式/饱和脂肪和胆固醇以及果糖甜味饮料的饮食,似乎会增加内脏脂肪堆积并刺激肝脏脂质积累,进而发展为非酒精性脂肪性肝炎,而减少热量摄入、增加大豆蛋白和乳清蛋白的摄入以及补充单不饱和脂肪酸、ω-3 脂肪酸和益生菌则具有预防和治疗作用。此外,胆碱、纤维、咖啡、绿茶和适量饮酒可能是 NAFLD 的保护因素。基于现有数据,通过低热量饮食单独或与运动和行为改变相结合实现至少 3-5%的体重减轻通常可以减轻肝脂肪变性,而需要减轻 10%的体重可能有助于改善肝坏死性炎症。持续坚持饮食而非实际的饮食类型是成功减轻体重的主要预测因素。此外,对于肥胖或体重正常的 NAFLD 患者,健康饮食除了减轻体重之外还有其他益处。因此,营养是预防和治疗 NAFLD 的主要途径,NAFLD 患者应接受个性化的饮食建议。

相似文献

1
Role of diet and nutritional management in non-alcoholic fatty liver disease.饮食和营养管理在非酒精性脂肪性肝病中的作用。
J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:81-7. doi: 10.1111/jgh.12244.
2
Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.体重减轻:非酒精性脂肪性肝病治疗的基石。
Minerva Gastroenterol Dietol. 2010 Jun;56(2):159-67.
3
Practical approaches to the nutritional management of nonalcoholic fatty liver disease.非酒精性脂肪性肝病营养管理的实用方法
Integr Med Res. 2014 Dec;3(4):192-197. doi: 10.1016/j.imr.2014.09.003. Epub 2014 Sep 19.
4
Non-alcoholic steatohepatitis: pathogenesis and novel therapeutic approaches.非酒精性脂肪性肝炎:发病机制与新型治疗方法。
J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:68-76. doi: 10.1111/jgh.12212.
5
Non-alcoholic fatty liver disease: the hepatic consequence of obesity and the metabolic syndrome.非酒精性脂肪性肝病:肥胖和代谢综合征的肝脏后果。
Proc Nutr Soc. 2010 May;69(2):211-20. doi: 10.1017/S0029665110000030. Epub 2010 Feb 17.
6
Nutrition and physical activity in NAFLD: an overview of the epidemiological evidence.非酒精性脂肪性肝病(NAFLD)中的营养与身体活动:流行病学证据概述。
World J Gastroenterol. 2011 Aug 7;17(29):3377-89. doi: 10.3748/wjg.v17.i29.3377.
7
Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.营养调控非酒精性脂肪性肝病和胰岛素抵抗:人体数据。
Curr Opin Clin Nutr Metab Care. 2010 Nov;13(6):709-14. doi: 10.1097/MCO.0b013e32833f4b34.
8
[Non-alcoholic fatty liver disease in children: a new complication of obesity].儿童非酒精性脂肪性肝病:肥胖的一种新并发症
Ned Tijdschr Geneeskd. 2008 Nov 8;152(45):2443-7.
9
The central role of the non alcoholic fatty liver disease in metabolic syndrome.非酒精性脂肪性肝病在代谢综合征中的核心作用。
Rev Med Chir Soc Med Nat Iasi. 2012 Apr-Jun;116(2):425-31.
10
Non-alcoholic fatty liver disease.非酒精性脂肪性肝病。
J Diabetes. 2012 Sep;4(3):266-80. doi: 10.1111/j.1753-0407.2012.00204.x.

引用本文的文献

1
Lifestyle Intervention is Effective in Reversal of Fibrosis in NAFLD Patients: Results from a Retrospective Real-World Study.生活方式干预对非酒精性脂肪性肝病患者的纤维化逆转有效:一项回顾性真实世界研究的结果
J Clin Exp Hepatol. 2025 Nov-Dec;15(6):102598. doi: 10.1016/j.jceh.2025.102598. Epub 2025 May 22.
2
Unraveling MASLD: The Role of Gut Microbiota, Dietary Modulation, and AI-Driven Lifestyle Interventions.解析代谢相关脂肪性肝病:肠道微生物群、饮食调节及人工智能驱动的生活方式干预的作用
Nutrients. 2025 May 4;17(9):1580. doi: 10.3390/nu17091580.
3
Unraveling the Association Between Cheese Consumption and Non-Alcoholic Fatty Liver Disease: Insights From a Two-Sample Mendelian Randomization Analysis.
解析奶酪消费与非酒精性脂肪性肝病之间的关联:来自两样本孟德尔随机化分析的见解
Food Sci Nutr. 2025 May 10;13(5):e70213. doi: 10.1002/fsn3.70213. eCollection 2025 May.
4
HEPNET Position Statement-I, Case Definition, Classification, Screening & Diagnosis of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Pakistan: A Resource for Primary and Secondary Care Physicians.巴基斯坦肝脏网络立场声明 - I,代谢功能障碍相关脂肪性肝病(MASLD)的病例定义、分类、筛查与诊断:基层和二级医疗医生资源
Pak J Med Sci. 2025 Mar;41(3):929-938. doi: 10.12669/pjms.41.3.10081.
5
Lipid profile and non-alcoholic fatty liver disease detected by ultrasonography: is systemic inflammation a necessary mediator?血脂谱与超声检查发现的非酒精性脂肪性肝病:全身炎症是必要的介导因素吗?
Ann Med. 2025 Dec;57(1):2480250. doi: 10.1080/07853890.2025.2480250. Epub 2025 Mar 17.
6
Exercise and Berberine Intervention Ameliorate High-Fat Diet-Induced MAFLD by Regulating Gut Microbiota and Hepatic Fatty Acid Beta-Oxidation.运动和小檗碱干预通过调节肠道微生物群和肝脏脂肪酸β-氧化改善高脂饮食诱导的MAFLD。
J Inflamm Res. 2025 Feb 26;18:2837-2854. doi: 10.2147/JIR.S498782. eCollection 2025.
7
Prophylactic effects of nutrition, dietary strategies, exercise, lifestyle and environment on nonalcoholic fatty liver disease.营养、饮食策略、运动、生活方式及环境对非酒精性脂肪性肝病的预防作用。
Ann Med. 2025 Dec;57(1):2464223. doi: 10.1080/07853890.2025.2464223. Epub 2025 Feb 12.
8
Dietary Influences on Gut Microbiota and Their Role in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).饮食对肠道微生物群的影响及其在代谢功能障碍相关脂肪性肝病(MASLD)中的作用
Nutrients. 2024 Dec 31;17(1):143. doi: 10.3390/nu17010143.
9
Metabolic dysfunction-associated steatotic liver disease and gastroesophageal reflux disease: a mendelian randomization study in European and East Asian populations.代谢功能障碍相关脂肪性肝病与胃食管反流病:欧洲和东亚人群的孟德尔随机化研究
Front Genet. 2024 Dec 5;15:1428334. doi: 10.3389/fgene.2024.1428334. eCollection 2024.
10
Cardiolipin deficiency disrupts electron transport chain to drive steatohepatitis.心磷脂缺乏会破坏电子传递链,从而引发脂肪性肝炎。
bioRxiv. 2025 Mar 27:2024.10.10.617517. doi: 10.1101/2024.10.10.617517.